These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 15122328

  • 21. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH.
    Chem Biol Interact; 2006 Mar 25; 160(2):123-33. PubMed ID: 16458870
    [Abstract] [Full Text] [Related]

  • 22. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D, Thiel S, Stella MC, Stürzebecher A, Schweinitz A, Steinmetzer T, Stürzebecher J, Uhland K.
    Int J Oncol; 2005 Oct 25; 27(4):1061-70. PubMed ID: 16142324
    [Abstract] [Full Text] [Related]

  • 23. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A, Götze T, Korc M.
    Cancer Res; 2007 Nov 01; 67(21):10309-16. PubMed ID: 17974973
    [Abstract] [Full Text] [Related]

  • 24. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
    Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Merchant M, Schwall R, Westphal M, Lamszus K.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6144-52. PubMed ID: 17062691
    [Abstract] [Full Text] [Related]

  • 25. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM, Brown KR, Shih W, Wigle DA, Radulovich N, Jurisica I, Tsao MS.
    Oncogene; 2006 Jan 05; 25(1):91-102. PubMed ID: 16158056
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
    Hecht M, Papoutsi M, Tran HD, Wilting J, Schweigerer L.
    Cancer Res; 2004 Sep 01; 64(17):6109-18. PubMed ID: 15342394
    [Abstract] [Full Text] [Related]

  • 29. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL, Zhang SL, Lu YM, Jiang JY, Zhu XY.
    Ai Zheng; 2006 May 01; 25(5):570-5. PubMed ID: 16687076
    [Abstract] [Full Text] [Related]

  • 30. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH, Moon SK, Bae JH, Lee JH, Han JH, Kim K, Choi EC.
    Acta Otolaryngol; 2006 Jan 01; 126(1):88-94. PubMed ID: 16308260
    [Abstract] [Full Text] [Related]

  • 31. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac.
    De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M.
    FASEB J; 2004 Jun 01; 18(9):1016-8. PubMed ID: 15059978
    [Abstract] [Full Text] [Related]

  • 32. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM, Runyon ST, Santell L, Quan C, Yao X, Kirchhofer D, Skelton NJ, Lazarus RA.
    J Mol Biol; 2009 Jan 09; 385(1):79-90. PubMed ID: 18973760
    [Abstract] [Full Text] [Related]

  • 33. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B, Xia S, Abounader R, Laterra J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633
    [Abstract] [Full Text] [Related]

  • 34. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 35. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, Sugahara K, Yamada Y, Hayashi T, Nakashima M, Taguchi T, Mano H, Kamihira S, Tomonaga M.
    Int J Oncol; 2008 Oct 01; 33(4):697-703. PubMed ID: 18813782
    [Abstract] [Full Text] [Related]

  • 36. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.
    Eur Urol; 2009 Feb 01; 55(2):441-9. PubMed ID: 18395325
    [Abstract] [Full Text] [Related]

  • 37. Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model.
    Liu HJ, Wu CT, Duan HF, Wu B, Lu ZZ, Wang L.
    Surgery; 2006 Sep 01; 140(3):441-7. PubMed ID: 16934607
    [Abstract] [Full Text] [Related]

  • 38. Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells.
    Hara S, Nakashiro K, Goda H, Hamakawa H.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):123-8. PubMed ID: 18355439
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K, Nakamura T, Sakai K, Nakamura T.
    Proteomics; 2008 Aug 23; 8(16):3360-70. PubMed ID: 18646008
    [Abstract] [Full Text] [Related]

  • 40. Filamin a mediates HGF/c-MET signaling in tumor cell migration.
    Zhou AX, Toylu A, Nallapalli RK, Nilsson G, Atabey N, Heldin CH, Borén J, Bergo MO, Akyürek LM.
    Int J Cancer; 2011 Feb 15; 128(4):839-46. PubMed ID: 20473907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.